Cellular reprogramming and fate conversion

Masaki Ieda

Research output: Chapter in Book/Report/Conference proceedingChapter


Cellular reprogramming and fate conversion have long been recognized in somatic nuclear transfer and cell fusion experiments. The potency of specific transcription factors as cell fate determinants was first demonstrated by the discovery of MyoD, a master gene for skeletal muscle differentiation, and by the subsequent identification of several genes as lineage-converting factors within the blood cell lineage. These pioneer works led to the landmark study by Dr. Yamanaka and colleagues in 2006 that is reprogramming of somatic cells into a pluripotent state by transduction of the four stem cell-specific transcription factors, Oct4, Sox2, Klf4, and c-Myc. This study fundamentally altered the approach to regenerative medicine and also inspired a broad strategy to generate desired cell types by introducing combinations of lineage-specific transcription factors. In fact, it has been demonstrated that a diverse range of cell types, such as pancreatic β cells, neurons, cardiomyocytes, and hepatocytes, could be directly induced from heterologous cells by combinations of lineage-specific reprogramming factors. This chapter reviews the pioneer and recent works of cellular reprogramming and fate conversion, and also discusses the future perspective and challenges of using this technology in regenerative medicine.

Original languageEnglish
Title of host publicationAdvances in Stem Cell Research
PublisherHumana Press Inc.
Number of pages15
ISBN (Electronic)9781617799402
ISBN (Print)9781617799396
Publication statusPublished - 2012 Jan 1
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Cellular reprogramming and fate conversion'. Together they form a unique fingerprint.

Cite this